内分泌系统疾病
一型糖尿病
1 型糖尿病(T1D)是一种自身免疫性疾病,其中免疫系统攻击并破坏生成胰岛素的细胞。胰岛素对于控制血糖水平至关重要。这意味着 T1D 患者必须终生依赖胰岛素注射来控制血糖。
研究表明,移植干细胞可以通过生成胰岛素分泌细胞来帮助逆转糖尿病。许多临床试验正在研究使用干细胞生成胰岛 β 细胞的潜力,这样 T1D 患者将不再需要依赖胰岛素。
临床试验课题 | 临床试验编号 |
---|---|
Is it safe and effective to use mesenchymal stem cells from the umbilical cord to treat type 1 diabetes? |
NCT01954147
Qingdao University |
Will umbilical cord derived mesenchymal stem cell infusion signal beta-cells to regenerate to improve diabetic control. |
NCT01413035
Fuzhou General Hospital |
Effectiveness of using sequential transplantation of umbilical cord stem cells and pancreatic islet cells to treat diabetes in children and adolescents. |
NCT01216865
Children’s Hospital of Fudan University |
二型糖尿病
2 型糖尿病(T2D)是由于胰腺中的 β 细胞未能产生足够的胰岛素而导致的,胰岛素负责维持血糖水平。一旦确诊,这种代谢性疾病的治疗取决于疾病的严重程度,通常采用药物治疗(如:二甲双胍、磺脲类药物)、饮食改变和锻炼。
目前正在研究几种不同类型的干细胞用于治疗 T2D。以下是一些临床试验的列表,旨在研究脐带干细胞用于治疗这种慢性疾病的潜力。
临床试验课题 | 临床试验编号 |
---|---|
Can umbilical cord mesenchymal stem cells be combined with standard drugs like Liraglutide to observe better outcomes with T2D? |
NCT01954147
Diabetes Care Center of Nanjing Military Command, Fujian, China |
Safety and effectiveness of combining umbilical cord and placenta-derived mesenchymal stem cells with oral drugs used to treat T2D |
NCT01413035
Shandong University |
Using umbilical cord mesenchymal stem cell injections to avoid the T2D complications associated with diabetic foot |
NCT01216865
Qingdao University |
肠道克隆氏症
克罗恩病患者因消化道中的炎症而经历腹痛、腹泻、疲劳、体重减轻和营养不良。这是炎症性肠病(IBD)之一,疼痛难忍、使人虚弱,有时还可能引发危及生命的并发症。
目前没有治愈克罗恩病的方法,现有治疗方法主要集中在减轻症状。由于干细胞具有再生能力,研究人员正在探索利用干细胞“重置”免疫系统的可能性——通过生成新的细胞来减少炎症、促进修复,并抑制导致该病的免疫反应。
临床试验课题 | 临床试验编号 |
---|---|
Testing the use of umbilical cord mesenchymal stem cells to treat patients with hormone controlled Crohn’s disease |
NCT02445547
Fuzhou General Hospital |
Phase I/IIa Clinical Trials looking at safety of injecting FURESTEM-CD stem cells into patients with moderately active Crohn’s disease |
NCT02926300
Kang Stem Biotech Co., Ltd. Korea |
Evaluating the safety and clinical benefits of autologuous hematopoietic stem cell transplantation rescue in the treatment of refractory Crohn’s disease |
NCT03000296
Beneficencia Portuguesa Brazil |
Using human placental derived stem cells (PDA001) to treat Crohn’s disease |
NCT01769755
Celularity Incorporated. Warren, NJ, USA |
其他代谢性疾病
新陈代谢是指身体内发生的化学反应,用于正确地分解营养物质。当身体无法处理代谢产物时,就会引发代谢紊乱,这可能是由于肝脏或胰腺功能不正常,或是由于酶缺乏所导致的。遗传性代谢紊乱发生在一个人遗传了有缺陷的基因,无法产生特定的酶。
干细胞,特别是造血干细胞,正在被探索用于治疗代谢紊乱。
临床试验课题 | 临床试验编号 |
---|---|
Can MGTA-456 be used to enhance the effectiveness of umbilical cord blood transplants in patients with inherited metabolic diseases? |
NCT03406962
University of Minnesota |
Assessing the safety of transplanting human placental-derived stem cells AND unrelated and related cord blood into patients with malignant haematological and non-malignant disorders |
NCT01586455
New York Medical College |